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168a Sunday, March 1, 2009with>70% of the labeling in the b2 subunit. [3H]chlorpromazine subunit label-
ing was inhibited (~40%) by the non-competitive antagonist PCP (Fig 1).When HPLC-purified EndoLys-C digests of [3H]chlorpromazine-labeled b2
subunit was sequenced, a PCP-inhibitable 3H release at cycle 6 was evident,
consistent with labeling of b2Ser246 (M2-6), the position photolabeled by
[3H]chlorpromazine in the Torpedo nAChR ion channel. Sequence analyses
of HPLC-purified EndoLys-C/V8 protease digests of a4 and b2 subunits photo-
labeled by [3H]TDBzl-etomidate indicated the presence of multiple sites of 3H
incorporation. Studies are in progress to identify amino acids labeled by
[3H]TDBzl-Etomidate and [3H]chlorpromazine.
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The basic molecular mechanisms underlying the muscular weakness initiated
early during thyroid dysfunction are poorly understood. In this work we have ex-
plored how the acute and chronic alterations of thyroid hormones (THs) affect the
acetylcholine receptor (AChR) channel function in the neuromuscular junction
(NMJ).Acutemethimazole (MMI) treatment produced a significant (p<0.005) re-
duction inweight of euthyroidmice of 8.64%, induced by a transient hyperthyroid
phase. This result is compatible with the loss of weight produced acutely by T3
(1mg/g-bw) of 4.11%. The resulting action of these acute treatments is a signifi-
cantly (p<0.001) reduced muscular strength by MMI (58.0%) and T3 (52.9%)
when compared to sham animals. The hypothyroidism induced by the chronic
MMI treatment causes a reduced daily weight gain of 76.5%. Focal recordings
of miniature endplate currents (MEPCs) in isolated NMJ of chronically MMI-
treated mice revealed a significant (p<0.001) reduction in the frequency
(57.7%), amplitude (59.3%), and decay time (66.7%). The electrophysiological
results appear to be related to themembrane-lipidmetabolism inparticular choles-
terol, since NMJ of hypothyroid mice treated with methyl-beta-cyclodextrin
(MbCD) recover theMEPCs normal characteristics. This data also agreeswith re-
sults where the MEPCs’ decay time 1.455 0.06 ms (n¼8) of fat euthyroid mice
differs significantly (p<0.001) from those of slim animals 1.015 0.08ms (n¼7).
The relationship between weight (w) and decay time (t) is well-described by the
equation: t¼ -0.00447wþ 2.456. We propose that membrane cholesterol in the
NMJcouldbean important target for the in vivo regulationof synaptic activitydur-
ing thyroid dysfunction. Importantly, the docking of cholesterol to the AChR oc-
curs in the C418 vicinity, a highly relevant residue in the protein-lipid interface.
NIH 5S06 GM050595 and G12 RR03035 to LVR
871-Pos Board B750
Role of Membrane Cholesterol Levels in the Lateral Diffusion and Func-
tion of the Novel Slow Channel Congenital Myasthenia Syndrome
aC418W AChR Mutant
Jessica Oyola-Cintro´n1, Daniel Caballero-Rivera1, Leomar Ballester1,
Karla Ve´lez-Arroyo1, Jomarie Garcı´a-Matos1, Leonardo Martı´nez2,
Carlos J. Nogueras1, Orestes Quesada1, Jose´ Garcı´a3, Walter I. Silva3,
Jose´ A. Lasalde-Dominicci1.
1University of Puerto Rico, Rio Piedras Campus, San Juan, PR, USA,
2California State University Dominguez Hills, Carson, CA, USA, 3University
of Puerto Rico, Medical Sciences Campus, School of Medicine, San Juan,
PR, USA.
There is a critical need for understanding the regulation of acetylcholine receptor
(AChR) function and dynamics by cholesterol. Indeed, lipid-protein interactions
are known to regulate the function and dynamics of ligand-gated ion channels;
however, the underlying mechanisms are poorly understood. The novel Slow
Channel Congenital Myasthenia Syndrome (SCCMS) AChR mutant aC418Wis the first lipid-exposed mutation identified in a patient (Shen et al., 2006).
This AChR mutation was shown to be cholesterol-sensitive (Santiago et al.,
2001) and to accumulate in caveolin1-positive microdomains (Baez-Pagan
et al., 2008). The objective of this study is to gain insight into the mechanism
by which lateral segregation into specialized raft membrane microdomains regu-
lates the activatable pool of AChRs. We performed Fluorescent Recovery After
Photobleaching (FRAP) experiments and whole-cell patch clamp recordings of
GFP-encoding mus musculus AChRs transfected into HEK 293 cells under cho-
lesterol enrichment anddepletion conditions to assess the role of cholesterol levels
in the diffusion and functionality of theAChR(WTandaC418W).Our results fur-
ther demonstrate the cholesterol-sensitive nature of the aC418W mutant as both
lateral diffusion andmobile fraction aremodified by either cholesterol enrichment
or depletion differently in the aC418W mutant when compared to the WT. Fur-
thermore, the low mobile fraction (<20%) displayed by the AChR provides fur-
ther evidence of its trafficking to caveolin-positive microdomains. Because our
methodological approach combines FRAP and electrophysiological experiments,
our results provide a framework to understand the structural and functional basis
for the partition of AChRs into specialized membrane microdomains.
This work was supported in part by grants from NIH, RO1GM56371-12,
NCRR 1S0RR13705 and SNRP U54NS0430311.
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Steroids and free fatty acids (FFA) are non-competitive antagonists of the nico-
tinic acetylcholine receptor (AChR). Their site of action is purportedly located at
the lipid-AChR interface, but their exact mechanism of action is still unknown.
Herewe studied the effect of structurally different free fatty acids and steroids on
the conformational equilibrium of the AChR in T. californica receptor-rich
membranes. We took advantage of the higher affinity of the fluorescent AChR
open channel blocker, crystal violet (CrV), for the desensitized state than for
the resting state. Increasing concentrations of steroids and certain cis-unsatu-
rated free fatty acids decreased the KD of CrV in the absence of agonist. The po-
sition of the double bond at the hydrocarbon chain of cis-monounsaturated fatty
acids appears to be critical for their effect on the AChR resting conformation
state. All cis-unsaturated fatty acids tested, but not trans-unsaturated or saturated
fatty acids, caused an increase of the KD value in the presence of agonist. This
latter effect was also observed with membrane treatments that caused opposite
effects on membrane polarity (phospholipase A2 treatment or temperature in-
crease, which decreased or increased the membrane polarity, respectively).
Quenching by spin-labeled fatty acids of pyrene-labeled AChR reconstituted
into model membranes, with the label located at the gM4 transmembrane seg-
ment, disclosed the occurrence of conformational changes induced by steroids
and cis-FFA. These results suggest that the direct contact between exogenous
lipids and the AChR transmembrane segments removes the AChR from its rest-
ing state and thatmembrane polaritymodulates theAChRactivation equilibrium
by an independent mechanism.
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The nicotinic acetylcholine receptor (nAChR) is a cation-selective channel cen-
tral to both neuronal and muscular processes and is considered the prototype for
ligand-gated ion channels, motivating a structural determination effort that
spanned several decades. Purified nAChR must be reconstituted in a mixture
containing cholesterol to function. Proposed modes of interaction between cho-
lesterol and the protein range from specific binding to indirect membrane-me-
diated mechanisms. However the underlying cause of nAChR sensitivity to
cholesterol remains controversial, in part because the vast majority of func-
tional studies were conducted before a medium resolution structure was re-
ported. We show that the nAChR contains internal sites capable of containing
cholesterol, whose occupation stabilizes the protein structure. We detect sites at
the protein-lipid interface as conventionally predicted from functional data, as
well as deeply buried sites that are not usually considered. Molecular dynamics
simulations reveal that occupation of both superficial and deeply buried sites
most effectively preserves the experimental structure; the structure collapses
in the absence of bound cholesterol. In particular, we find that bound choles-
terol directly supports contacts between the agonist binding domain and the
pore that are thought to be essential for activation of the receptor. These results
likely apply to those other ion channels within the Cys-loop superfamily that
are dependent on cholesterol, such as the GABA receptor.
